NICOLE BRANUM: Open Payments
NPI 1700208345 · BEVERLY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,627 in 115 payments from 18 companies in 2025. Trend: 2023 $2,516 · 2024 $3,187 · 2025 $2,627
Food & beverage: $2,544Education: $83
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $301 |
| GENZYME CORPORATION | 9 | $286 |
| ABBVIE INC. | 17 | $275 |
| Janssen Biotech, Inc. | 7 | $273 |
| Galderma Laboratories, L.P. | 16 | $233 |
| Lilly USA, LLC | 10 | $223 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $221 |
| Novartis Pharmaceuticals Corporation | 7 | $153 |
| Organon LLC | 8 | $142 |
| Incyte Corporation | 4 | $100 |
Products named: DUPIXENT, CIBINQO, TREMFYA, NEMLUVIO, TALTZ, SKYRIZI, RINVOQ, ILUMYA.
Industry payments across MA — which companies pay providers there.
